Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Surface Microbiota Transplantation for Dry Eye Disease
NCT07298811Phase 2Completed
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in dry eye disease (DED) (3 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Visual Analog Scale for Ocular Discomfort at 4 weeks. Started Dec 2025; status: completed.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07298811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07298811.